Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
27625 | 225 | 55.5 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
262 | 3 | AUTOPHAGY//RESVERATROL//HISTONE DEACETYLASE INHIBITOR | 44558 |
1531 | 2 | HISTONE DEACETYLASE INHIBITOR//HISTONE DEACETYLASE//HDAC INHIBITOR | 7464 |
27625 | 1 | METABOLIC MEMORY//IL RISK ASSESSMENT INTERVENT STUDIES//HYPERGLYCEMIC MEMORY | 225 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | METABOLIC MEMORY | authKW | 970131 | 10% | 31% | 23 |
2 | IL RISK ASSESSMENT INTERVENT STUDIES | address | 694998 | 6% | 39% | 13 |
3 | HYPERGLYCEMIC MEMORY | authKW | 310197 | 2% | 57% | 4 |
4 | SET7 METHYLTRANSFERASE | authKW | 271426 | 1% | 100% | 2 |
5 | EPIGENET HUMAN HLTH DIS | address | 224930 | 5% | 15% | 11 |
6 | EPIGEN PROFILING IL | address | 222067 | 3% | 27% | 6 |
7 | 5UV39H1 | authKW | 135713 | 0% | 100% | 1 |
8 | AAL LIFE SCI SYST ENGN | address | 135713 | 0% | 100% | 1 |
9 | AFFILIATED PEOPLES HOSP 6SHANGHAI KEY CLINICAL C | address | 135713 | 0% | 100% | 1 |
10 | AMPK AND SIRT1 | authKW | 135713 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 1265 | 29% | 0% | 66 |
2 | Urology & Nephrology | 563 | 15% | 0% | 34 |
3 | Biochemistry & Molecular Biology | 160 | 25% | 0% | 57 |
4 | Medicine, Research & Experimental | 124 | 10% | 0% | 22 |
5 | Genetics & Heredity | 94 | 10% | 0% | 22 |
6 | Physiology | 72 | 7% | 0% | 16 |
7 | Peripheral Vascular Diseases | 45 | 5% | 0% | 11 |
8 | Cell Biology | 31 | 8% | 0% | 18 |
9 | Toxicology | 26 | 4% | 0% | 9 |
10 | Cardiac & Cardiovascular System | 24 | 5% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IL RISK ASSESSMENT INTERVENT STUDIES | 694998 | 6% | 39% | 13 |
2 | EPIGENET HUMAN HLTH DIS | 224930 | 5% | 15% | 11 |
3 | EPIGEN PROFILING IL | 222067 | 3% | 27% | 6 |
4 | AAL LIFE SCI SYST ENGN | 135713 | 0% | 100% | 1 |
5 | AFFILIATED PEOPLES HOSP 6SHANGHAI KEY CLINICAL C | 135713 | 0% | 100% | 1 |
6 | CARDIOVASCCARDIOVASC IMAGING CLIN CORE | 135713 | 0% | 100% | 1 |
7 | CHILDRENS HOSPTRANSPLANTAT NEPHROL | 135713 | 0% | 100% | 1 |
8 | DIABET BIOINFORMAT CORE | 135713 | 0% | 100% | 1 |
9 | DIABET COMPLICAT OBES METAB | 135713 | 0% | 100% | 1 |
10 | EXCELLENCE AGING EXPT CLIN SCI | 135713 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CURRENT DIABETES REPORTS | 8196 | 3% | 1% | 7 |
2 | JOURNAL OF DIABETES RESEARCH | 5393 | 3% | 1% | 6 |
3 | EPIGENOMICS | 2638 | 1% | 1% | 3 |
4 | DIABETES | 2205 | 6% | 0% | 14 |
5 | EPIGENETICS | 2117 | 1% | 1% | 2 |
6 | JOURNAL OF DIABETES AND ITS COMPLICATIONS | 1199 | 2% | 0% | 4 |
7 | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1187 | 4% | 0% | 8 |
8 | DIABETES-METABOLISM RESEARCH AND REVIEWS | 846 | 1% | 0% | 3 |
9 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 736 | 3% | 0% | 6 |
10 | KIDNEY INTERNATIONAL | 588 | 4% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MIAO, F , CHEN, Z , GENUTH, S , PATERSON, A , ZHANG, LX , WU, XW , LI, SM , CLEARY, P , RIGGS, A , HARLAN, DM , ET AL (2014) EVALUATING THE ROLE OF EPIGENETIC HISTONE MODIFICATIONS IN THE METABOLIC MEMORY OF TYPE 1 DIABETES.DIABETES. VOL. 63. ISSUE 5. P. 1748-1762 | 21 | 47% | 46 |
2 | REDDY, MA , ZHANG, EL , NATARAJAN, R , (2015) EPIGENETIC MECHANISMS IN DIABETIC COMPLICATIONS AND METABOLIC MEMORY.DIABETOLOGIA. VOL. 58. ISSUE 3. P. 443 -455 | 27 | 28% | 41 |
3 | CHEN, Z , MIAO, F , PATERSON, AD , LACHIN, JM , ZHANG, LX , SCHONES, DE , WU, XW , WANG, JH , TOMPKINS, JD , GENUTH, S , ET AL (2016) EPIGENOMIC PROFILING REVEALS AN ASSOCIATION BETWEEN PERSISTENCE OF DNA METHYLATION AND METABOLIC MEMORY IN THE DCCT/EDIC TYPE 1 DIABETES COHORT.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. VOL. 113. ISSUE 21. P. E3002 -E3011 | 21 | 34% | 3 |
4 | LI, XX , LI, CY , SUN, GD , (2016) HISTONE ACETYLATION AND ITS MODIFIERS IN THE PATHOGENESIS OF DIABETIC NEPHROPATHY.JOURNAL OF DIABETES RESEARCH. VOL. . ISSUE . P. - | 26 | 30% | 0 |
5 | CARAMORI, ML , KIM, Y , NATARAJAN, R , MOORE, JH , RICH, SS , MYCHALECKYJ, JC , KURIYAMA, R , KIRKPATRICK, D , MAUER, M , (2015) DIFFERENTIAL RESPONSE TO HIGH GLUCOSE IN SKIN FIBROBLASTS OF MONOZYGOTIC TWINS DISCORDANT FOR TYPE 1 DIABETES.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 100. ISSUE 6. P. E883 -E889 | 17 | 41% | 1 |
6 | VILLENEUVE, LM , REDDY, MA , NATARAJAN, R , (2011) EPIGENETICS: DECIPHERING ITS ROLE IN DIABETES AND ITS CHRONIC COMPLICATIONS.CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. VOL. 38. ISSUE 7. P. 401 -409 | 22 | 31% | 46 |
7 | REDDY, MA , PARK, JT , NATARAJAN, R , (2013) EPIGENETIC MODIFICATIONS IN THE PATHOGENESIS OF DIABETIC NEPHROPATHY.SEMINARS IN NEPHROLOGY. VOL. 33. ISSUE 4. P. 341-353 | 24 | 26% | 22 |
8 | REDDY, MA , NATARAJAN, R , (2015) RECENT DEVELOPMENTS IN EPIGENETICS OF ACUTE AND CHRONIC KIDNEY DISEASES.KIDNEY INTERNATIONAL. VOL. 88. ISSUE 2. P. 250 -261 | 31 | 18% | 10 |
9 | GAO, CL , CHEN, G , LIU, L , LI, X , HE, JH , JIANG, L , ZHU, JH , XU, Y , (2013) IMPACT OF HIGH GLUCOSE AND PROTEASOME INHIBITOR MG132 ON HISTONE H2A AND H2B UBIQUITINATION IN RAT GLOMERULAR MESANGIAL CELLS.JOURNAL OF DIABETES RESEARCH. VOL. . ISSUE . P. - | 15 | 44% | 4 |
10 | MAJUMDER, S , ADVANI, A , (2015) THE EPIGENETIC REGULATION OF PODOCYTE FUNCTION IN DIABETES.JOURNAL OF DIABETES AND ITS COMPLICATIONS. VOL. 29. ISSUE 8. P. 1337 -1344 | 20 | 29% | 2 |
Classes with closest relation at Level 1 |